Cancer Centers Nudge Oncologists Toward DPYD Testing as PGx Supporters Push For Guidelines Change
Several institutions, swayed by PGx experts and advocates, are setting up DPYD testing to avoid deadly chemo toxicities in patients even though the NCCN and FDA don't back it.
Cleveland Clinic Gets FDA Emergency Use Authorization for Molecular COVID-19, Flu Combo Test
The PCR-based test uses a previously authorized Roche SARS-CoV-2 and influenza assay in combination with a sample self-collection kit.
PathAI, Cleveland Clinic Collaborate on Pathology Algorithms
Under the five-year agreement, the partners will digitize hundreds of thousands of pathology specimens and link the data with clinical and molecular info.
FDA Grants EUAs for Cleveland Clinic COVID-19 PCR Test, Quest Diagnostics Sample Self-Collection Kit
The Cleveland Clinic's test uses self-collected nasal swab specimens, while Quest's kit is used to self-collect nasal specimens for molecular testing.
Personal Genome Diagnostics, Cleveland Clinic Join Forces to Advance Liquid Biopsy
Leaders from collaborating Cleveland Clinic institutes will work with PGDx to optimize its ctDNA test reporting and adapt its technology for new oncology applications.